Skin decontamination of mustards and organophosphates: Comparative efficiency of RSDL and Fuller's earth in domestic swine

Human and Experimental Toxicology

Volumn 26, Issue 2, 2007, Pages 135-141

  Taysse, L ^a   Daulon, S ^a   Delamanche, S ^a   Bellier, B ^a   Breton, P ^a  

^a CENTRE D ETUDES DU BOUCHET   (France)

Author keywords

Cholinesterases; Decontamination; Fuller's earth; RSDL; Skin; Sulphur mustard; VX

Indexed keywords

ANTIDOTE; FULLER EARTH; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MUSTARD GAS; ORGANOPHOSPHATE; REACTIVE SKIN DECONTAMINANT LOTION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ERYTHEMA; FEMALE; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN DECONTAMINATION; SKIN INJURY; SKIN TOXICITY; SWINE;

ALUMINUM COMPOUNDS; ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; DECONTAMINATION; DIACETYL; FEMALE; INFLAMMATION; MAGNESIUM COMPOUNDS; MUSTARD GAS; NECROSIS; ORGANOTHIOPHOSPHORUS COMPOUNDS; POLYETHYLENE GLYCOLS; SILICATES; SKIN; SUS SCROFA;

BRASSICACEAE; SUS SCROFA DOMESTICA;

EID: 34247201612     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107071866     Document Type: Article

References (25)

1. Okudera H, Morita H, Iwashita T. Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am J Emerg Med 1997; 127: 1042.
2. Suzuki T, Morita H, Ono K, Maekawa K, Nagai R, Yazaki Y. Sarin poisoning in Tokyo subway. Lancet 1995; 345: 980.
3. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical defense against mustard gas: toxic mechanisms and pharmacological implications;. CRC Press Inc., 1991.
4. Vogt RF, Dannenberg AM, Schofield BH, Hynes NA, Papirmeister B. Pathogenesis of skin lesions caused by sulphur mustard. Fund Appl Toxicol 1984; 4: 71-83.
5. Wormser U. Toxicology of mustard gas. Trends Pharmacol Sci 1991; 12: 164-67.
6. Marrs TC, Maynard RL, Sidell FR. Chemical warfare agents: toxicology and treatment. Wiley, 1996.
7. Yang YC, Szafraniec LL, Beaudry WT, Rohrbaugh DK. Oxidative detoxification of phosphonothiolates. J Am Chem Soc 1990; 12: 6621-27.
8. Who Report Geneva. Public health and chemical and biological weapons. 1970.
9. Shih ML, Korte WD, Smith JR, Szafraniec LL. Analysis and stability of the candidate sulfur mustard decontaminant S-330. J Appl Toxicol 1999; 19: S89-S95.
10. Sawyer TA, Parker D, Thomas N, Weiss MT, Bide RW. Efficacy of an oximate-based skin decontaminant against organophosphate nerve agents determined in vivo and in vitro. Toxicology 1991; 67: 267-77.
11. Sawyer TA, Weiss MT, Boulet CA, Hansen AS. Toxicity of organophosphate nerve agents and related phosphonylated oximes compared to their anticholinesterase activity in neuron clutures. Fund Appl Toxicol 1991; 17: 208-14.
12. Maynard RL, Beswick FW. Organophosphorus compounds as chemical warfare agents. In Ballantyne B, Marrs TC eds. Clinical and experimental toxicology of organophosphates and carbamates. Butterworth-Heinemann, 1992: 373-85.
13. Bhatti AS, Scott RC, Dyer A. In vitro percutaneous absorption: pig epidermal membrane as a model for human skin. J Pharm Pharmacol 1988; 40: 45.
14. Bronaugh RL, Maibach HI. Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in the human and monkeys. J Invest Dermatol 1985; 84: 180-83.
15. Moody RP, Franklin CA, Ritter L, Maibach HI. Dermal absorption of the phenoxy herbicides 2,4-D amine, 2,4-D isoctyl and 2,4,5-T in rabbits, rats, rhesus monkeys and humans: a cross species comparison. J Toxicol Environ Health 1990; 29: 237-45.
16. Knezevic DL, Tadic V, Cetkovic S. The efficacy of different decontaminants in rats and pigs percutaneously poisoned with organophosphates. Vet Human Pathol 1993; 35: 403-405.
17. Ellman GL, Courney KD, Andres V, Feathertone RH. A next and rapid colorimetric determination of acetylcholinesterase activies. Biochem Pharmacol 1961; 7: 88-95.
18. Reinfenrath WG, Chellquist EM, Shipwash EA, Jederberg WW. Evaluation of animal models for predicting skin penetration in man. Fund Appl Toxicol 1994; 4: S224-30.
19. Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative observations - an overview. Skin Pharmacol Appl 2000; 13: 229-34.
20. Danneberg AM. Vogt RF. Pathogenesis and treatment of skin lesions caused by sulphur mustard. DTIC Technical Report Program No. US Army Medical Research aned Development Command, 1987.
21. Papirmeister B, Gross CL, Petralli JP, Meier HL. Pathology produced by sulphur mustard in human skin grafts on athymic nude mice. Gross and light microscopy changes. J Toxicol Cutaneous Ocult Toxicol 1988; 3: 393-408.
22. Lundy PM, Hamilton MG, Hill I, Conley J, Sawyer TW. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil Med 2004; 169: 856-62.
23. Chilcott RP, Dalton CH, Hill I. Skin absorption of the nerve agent VX. Part I. In vivo studies using the domestic white pig. Biosci Rev 2002; Abstract 1473.
24. Yang YC. Chemical detoxification of nerve agent VX. Acc Chem Res 1999; 32: 109-15.
25. Evison D, Hinsley D, Rice P. Chemical weapons. BMJ 2002; 324: 332-35.